Table 2.
Nutraceuticals | Author and year | Type of Study | Number of patients | Outcome scoring system used | Results | Conclusion | Remarks |
---|---|---|---|---|---|---|---|
Boswellia | |||||||
Krishanu Sengupt,21 et al. | Randomized double-blind placebo controlled study | 75 | VAS, Lequesne's Functional Index, WOMAC, Cartilage degrading enzyme from synovial fluid |
Statistically and clinically significant improvement in pain score and physical function score, and reduction of cartilage degradation enzyme in synovial fluid | 5-Loxin® reduces pain and improves physical functioning significantly in OA patients; and it is safe for human consumption. 5-Loxin® may exert its beneficial effects by controlling inflammatory responses through reducing proinflammatory modulators, and it may improve joint health by reducing the enzymatic degradation of cartilage in OA patients. | 5-Loxin is Boswellia serrata extract enriched with 30% 3-O-acetyl-11-keto-beta-boswellic acid. | |
Belcaro G,22 et al. | Supplement registry | 55 | Kamofsky scale, WOMAC score, Treadmill test | The effect of supplement is significant higher than only using standard medicine | The difference between standard medicine and suppl. To SM was significant in favor of suppl. For all target measurement used in registry | ||
Belcaro G,23 et al. | A comparative study | 66 | WOMAC Score, treadmill test | In supplement plus standard medicine group WOMAC score reduced significantly. | The difference between SM and the flexiqule + SM was in favor of the management with supplement. | Flexiqule: Boswellia extract in capsule: safe and well tolerated. | |
Aflapin | |||||||
Krishanu Sengupt30 et al. | Randomized double-blind placebo controlled trial | 60 | VAS, Lequesene's Functional Index, WOMAC | Significant improvement in pain score and physical function score. Significant improvement in pain score and functional ability were recorded at the 7th day of treatment. | Aflapin and 5-Loxin reduce pain and improve physical functions significantly in OA subjects. Aflapin exhibited better efficacy compared to 5-Loxin. Both were safe. | ||
Amar A,31 et al. | Randomized double-blind placebo controlled trail | 152 | VAS score, Lequesne's functional index, WOMAC score | Significant reduction in all the pain score is observed in aflapin group by day 30. Significne reduction of VAS and LFI observed by day 5 | Aflapin is effective and safe in treatment of OA pt. and its effect shows as early as 5th day of starting treatment. | ||
Collagen paptide | |||||||
Kumar S55 et al. | Double-blind, placebo-controlled randomized trial | WOMAC, VAS, Quality of life (QOL) | Scores reduced significantly in collagen peptide group compared to placebo group | Collagen peptide found to be effective in reducing pain of OA knee | Collagen paptide was isolated from pork skin and bovine bone | ||
Lugo JP,56 et al. | Multicenter, randomized, placebo-controlled, double-blind trail | 191 | WOMAC, VAS, Lequesne Functional Index (LFI) | Significant improvement in UC II group compared to other GS and placebo group | UC=II improved symptoms in OA patients and well tolerated | Undenatured type II collagen obtained from chiken sternum cartilage However, further studies required for establishing its effect and mechanism of action |
|
Figueres Juher T53 et al. | Review study | 60 scientific studies | Hydrolyzed collagen reduces collagen damage and loss causing reduction in joint pain | Hydrolyzed collagen found to be effective in OAknee | |||
Curcumin | |||||||
Madhu K65et al. | A Randomized placebo-controlled trail | WOMAC subscalesand total score | Improved WOMAC score, joint temderness, crepitation, effusion, limitation of move,ents | Curcumin found effective in treatment of OA knee patients | Single blinded, small sample size, short duration | ||
Kuptniratsaikul V,67 et al.(2014) | Comparative study between curcuma domestica extract and ibuprofen | 345 | WOMAC score | Both group showed significant improvement in WOMAC score | Curcuma domestic a extract is an effective in treatment of OA with less side effects | Large sample size, proper blinding and randomization but short duration | |
Henrotin Y,68 et al. | Exploratory clinical trail | 22 | VAS score and blood markers | Significantly reduced circulating markers of collagen degradation, Coll2-1,Fib3-1,Fib3-2, Myeloperoxidase and VAS score reduced significantly | Flexofytol reduce inflation and thus reduce pain in OA patient | Flexofytol: another optimized curcumin formation with emulsifier polysorbate 80, Sample size of this study was small |
|
Nakagawa Y,71 et al. | Randomized, double-blind, placebo-controlled prospective study | Kellgren and Lawrence scale. Japanese Knee Osteoarthritis Measure |
Reduced severity of pain and rate of concomitant celecoxib use. No difference in JKOM | Theracurmin reduces pain significantly. | Large sample and longer duration required. | ||
Panahi Y,73 et al. | Randomized double-blind placebo-controlled trial | WOMAC,VAS, Lequesne's pain functional index | Significant reduction in all the score compare to placebo | Curcuminoids represent an effective and safe alternative treatment in OA. | |||
Kok-Yong Chin,62 et al. | Review study | Reduction in pain and improvement in physical function | Patients has better quality of life after taking curcumin | More well planned randomized control trails and enhanced curcumin formulation required | |||
Daily JW74et al. | Systematic review | 8 RCTs | Pain Visual Analog score, WOMAC score | Reduction of PVAS compared to placebo (p < .00001) in 3 RCTs, Reduction of WOMAC score in 4 RCTs, No significant difference in PVAS in 5 RCTs |
1000 mg/day is effective for treatment of arthritis. It is difficult to draw definitive conclusion due to total sample size, quality of primary study |
More rigorous and larger studies are needed to confirm therapeutic efficacy of turmeric for arthritis | |
Fish Oil | |||||||
Nuria Caturla,77 et al. | Randomized, double-blinded, placebo-controlled study | 45 | WOMAC, Lequesne's score | WOMAC, Lequesne's total score reduced 53% and 78% respectively | Standardized lemon verbena extract and Fish oil omega-3 fatty acid reduced pain and stiffness significantly | May be considered for further investigation as a alternative treatment. | |
Peanpadungrat P,78 et al. | Comparative study | 75 | VAS score, 100 m walking velocity, three steps walking time | Average score of patient satisfaction was 9.06 of 10. all parameters improved significantly | Safe and effective in mild to moderate OA knee pts. | ||
Hill CL,79 et al. | Randomized clinical trial of low dose versus high dose of fish oil | WOMAC pain and function score | Improvement in both the group, greater improvement in pain and functions score at 2 years in low-dose patients. No difference in cartilage volume loss. | Fish oil is an effective treatment in OAknee | |||
Boe C,75 et al. | Review study | In vitro studies: anti-inflammatory action, Canine trial: reduction in symptoms Human clinical trial: Not consistently sigmificant |
Long-term, well-designed studies required, and standardization of fish oil industry required | ||||
Senftleber NK,80 et al. | Systematic review | 42 | Grading of Recommendation Assessment, Development, and Evaluation (GRADE) | The standardized mean difference suggested unfavorable effect in OA patients | Evidence of marine oil using in alleviate pain arthritis patients was over all of the low quality | ||
Ginger | |||||||
Naderi Z81 et al. | double-blind randomized placebo-controlled clinical trial | 120 | Serum concentration of nitric oxide (NO) and hs-C reactive protein (hs-CRP | concentration of these markers declined more in the Ginger containing group | Ginger powder supplementation can reduce inflammatory markers | ||
Mozafarri – Khosravi82 et al. | randomized double-blind clinical trial | 120 | serum TNF-α and IL-1β level | both cytokines decreased in the Ginger containing group relative to the Placebo group | benefit in reducing inflammatory biomarkers | ||
Bartels EM83 et al. | Meta analysis of randomised placebo controlled trials | 593 | Hedges' standardized mean difference (SMD), and safety by risk ratio (RR) | Statistically significant pain reduction and a statistically significant reduction in disability were seen, both in favor of ginger. | modestly efficacious and reasonably safe but moderate quality evidence | ||
Paramdeep G84et al. | randomized open label study | 60 | VAS SCORE, WOMAC SCORE |
statistically significant improvement with time in all groups with patients who received both ginger and diclofenac treatments | Ginger powder has add-on effect with acceptable safety profile. | ||
Amorndoljai P85 et al. | comparative study comparing paired t score before and after treatment | 60 | KOOS, ISOA, PGA | statistically significant improved patient's global assessment, knee joint pain, symptoms, daily activities, sports activities, and quality of life | Application of Ginger extract nanoparticles relieves joint pain with symptomatic and improved quality of life | ||
Rondanelli M,86 et al. | A pilot study | Tegner Lysholm Knee Scoring,VAS,SF-36), anthropometric parameters,hydration | significant improvement of pain by Lysholm scale score, SF-36 | This study shows feasibility and safety data for the use of highly standardized ginger. | |||
Green tea | |||||||
Hashempur MH,93 et al. | Randomized open-label active-controlled clinical trial, Intervention group: green tea extract + diclofenac Control group: diclofenac |
VAS, total WOMAC | Mean difference of VAS pain, total WOMAC, and WOMAC physical functional score shows significant reduction compared with the control group. No significant difference between two groups in mean differences of WOMAC pain and stiffness scores. | Green tea extract can be considered as an adjunctive treatment for control of pain and betterment of knee joint physical function in OA knee pt. | Duration and sample size of this study is small. | ||
Rose Hip Extract | |||||||
Winther99 K et al. | Randomized, double-blind, placebo-controlled trail | WOMAC pain, stiffness, global assessment of severity of the disease | Significant reduction in WOMAC pain, and global assessment of severity of the disease | Reduces symptom of osteoarthritis | |||
Rossnagel K,100 et al. | Meta-analysis of RCT | 2 RCTs revied | 1st RCT:no improvement in knee flexion 2nd RCT: reduction of pain in RHP group |
In both studies RHP has moderate effect in OA patients | 1st RCT: parallel design 2nd RCT: crossover design In both studies sample size was small |
||
Christensen R,101 et al. | Meta analysis of RCT | 3 RCT reviewed | Reduction of pain score in RHP compared to placebo | Although sparse amount of data available, RHP reduces pain in OA pt. | In future, large-scale/long term trail require |